These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30476485)

  • 21. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania.
    Zhang K; Pompey JM; Hsu FF; Key P; Bandhuvula P; Saba JD; Turk J; Beverley SM
    EMBO J; 2007 Feb; 26(4):1094-104. PubMed ID: 17290222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine tuning therapeutic targeting of the sphingolipid biosynthetic pathway to treat atherosclerosis.
    Kim WS; Chalfant CE; Garner B
    Curr Vasc Pharmacol; 2006 Apr; 4(2):151-4. PubMed ID: 16611156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymes of sphingolipid metabolism in Drosophila melanogaster.
    Acharya U; Acharya JK
    Cell Mol Life Sci; 2005 Jan; 62(2):128-42. PubMed ID: 15666085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plant Sphingolipid Metabolism and Function.
    Luttgeharm KD; Kimberlin AN; Cahoon EB
    Subcell Biochem; 2016; 86():249-86. PubMed ID: 27023239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection mechanisms against aberrant metabolism of sphingolipids in budding yeast.
    Tani M; Funato K
    Curr Genet; 2018 Oct; 64(5):1021-1028. PubMed ID: 29556757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of fluorescent sphingolipid analogs to study lipid transport along the endocytic pathway.
    Marks DL; Singh RD; Choudhury A; Wheatley CL; Pagano RE
    Methods; 2005 Jun; 36(2):186-95. PubMed ID: 15905102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapy.
    Canals D; Clarke CJ
    Pharmacol Ther; 2022 Apr; 232():108005. PubMed ID: 34582834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of crosstalks between the Snf1 kinase complex and sphingolipid metabolism in S. cerevisiae via systems biology approaches.
    Borklu Yucel E; Ulgen KO
    Mol Biosyst; 2013 Nov; 9(11):2914-31. PubMed ID: 24056632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining Deep Sequencing, Proteomics, Phosphoproteomics, and Functional Screens To Discover Novel Regulators of Sphingolipid Homeostasis.
    Lebesgue N; Megyeri M; Cristobal A; Scholten A; Chuartzman SG; Voichek Y; Scheltema RA; Mohammed S; Futerman AH; Schuldiner M; Heck AJ; Lemeer S
    J Proteome Res; 2017 Feb; 16(2):571-582. PubMed ID: 28152593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
    Burns TA; Luberto C
    Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-Deoxysphingolipids.
    Lone MA; Santos T; Alecu I; Silva LC; Hornemann T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):512-521. PubMed ID: 30625374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options.
    Kacher Y; Futerman AH
    FEBS Lett; 2006 Oct; 580(23):5510-7. PubMed ID: 16970941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipid and sphingolipid metabolism in Leishmania.
    Zhang K; Beverley SM
    Mol Biochem Parasitol; 2010 Apr; 170(2):55-64. PubMed ID: 20026359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of structural organization of protein-synthesizing machinery from prokaryotes to eukaryotes.
    Ryazanov AG; Ovchinnikov LP; Spirin AS
    Biosystems; 1987; 20(3):275-88. PubMed ID: 3113506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal membrane dynamics as fine regulator of sphingolipid composition.
    Aureli M; Samarani M; Loberto N; Chiricozzi E; Mauri L; Grassi S; Schiumarini D; Prinetti A; Sonnino S
    Glycoconj J; 2018 Aug; 35(4):397-402. PubMed ID: 30145639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for coupled biogenesis of yeast Gap1 permease and sphingolipids: essential role in transport activity and normal control by ubiquitination.
    Lauwers E; Grossmann G; André B
    Mol Biol Cell; 2007 Aug; 18(8):3068-80. PubMed ID: 17553927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingolipids are essential for differentiation but not growth in Leishmania.
    Zhang K; Showalter M; Revollo J; Hsu FF; Turk J; Beverley SM
    EMBO J; 2003 Nov; 22(22):6016-26. PubMed ID: 14609948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.